Characteristic | Cases (DM) | Controls | P value |
---|---|---|---|
n | 82 | 86 | Â |
Gender (male) – n (%) | 61 (74) | 61 (74) | 0.615 |
Age (y) – mean (SD) | 62 (±8) | 62 (±7) | 0.941 |
BMI (kg/m2) – mean (SD) | 28 (±4) | 27 (±4) | 0.12 |
Active smoking – n (%) | 4 (5) | 6 (7) | 0.747 |
FRS – mean (SD) | 26 (±13) | 16 (±9) | <0.001 |
Comorbidities – n (%) | |||
 Hypertension | 45 (55) | 47 (55) | 0.976 |
 Hyperlipidemia | 61 (74) | 62 (72) | 0.737 |
Hypoglycemic medications – n (%) | |||
 Biguanides | 58 (70) | N/A |  |
 GLP1-RA | 3 (4) | N/A |  |
 DPP-4 antagonists | 25 (30) | N/A |  |
 SU/Meglitinides | 10 (12) | N/A |  |
 Insulin | 8 (10) | N/A |  |
Medications – n (%) | |||
 Beta blockers | 16 (20) | 12 (14) | 0.334 |
 Calcium channel blockers | 14 (17) | 17 (20) | 0.653 |
 ACEi/ARB | 33 (40) | 31 (36) | 0.575 |
 Diuretics | 4 (5) | 9 (10) | 0.175 |
 Statins | 53 (65) | 46 (54) | 0.142 |
Laboratory values – mean (SD) | |||
 Hemoglobin (g/dl) | 14 (±1) | 14 (±1) | 0.635 |
 Platelets (K/microL) | 222 (±54) | 216 (±52) | 0.401 |
 Fasting plasma glucose (mg/dl) | 136 (±29) | 91 (±8) | <0.001 |
 HbA1c (%) (mmol/mol) | 6.7 (±0.9) (49.7) | 5.4 (±0.3) (35.5) | <0.001 |
 LDL (mg/dl) | 109 (±24) | 121 (±24) | <0.001 |
 HDL (mg/dl) | 46 (±14) | 50 (±12) | 0.040 |
 Total Cholesterol (mg/dl) | 162 (±30) | 179 (±31) | <0.001 |
 eGFR (mL/min/1.73 m2) | 79 (±19) | 76 (±15) | 0.289 |